Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Lupus patients wanted: new italian registry hopes to unlock better care

NCT ID NCT07175610

Knowledge-focused Sponsor: Società Italiana di Allergologia, Asma e Immunologia Clinica Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

The LUNET project is creating a registry of 1,500 Italian adults with systemic lupus erythematosus (SLE). By collecting real-world data from clinics across Italy, researchers hope to better understand the disease and improve how it is managed in daily practice. This is an observational study, not a treatment trial, so participants will not receive any experimental therapy.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this registry could provide insights that help doctors better manage lupus in everyday practice and guide health policy decisions.
What could go wrong
This is an observational registry, not a treatment trial. It will not test any new drug or therapy, so it cannot directly lead to a cure or new treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 1,500 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2025

An estimate. Start dates often move.

Expected to finish

Dec 2035

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients with SLE according to the SLICC 2012 and/or ACR/EULAR 2019 classification criteria

Ages

18 years and older

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * age ≥ 18 years; * confirmed SLE diagnosis according to the SLICC 2012 and/or ACR/EULAR 2019 classification criteria; * provision of signed written informed consent prior to participation Exclusion Criteria: \-

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Systemic lupus erythematous (SLE) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

autoimmune disease connective tissue disorder systemic lupus erythematosus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Systemic lupus erythematous (SLE)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    16 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Allergologia e Immunologia Clinica, Azienda Ospedaliero-Universitaria di Cagliari

    Cagliari, Italy

  • Division of Internal Medicine and Clinical Immunology, Azienda Ospedaliera Universitaria Federico II

    Naples, Italy

  • Medicina Interna B - Azienda Ospedaliera Universitaria Integrata

    Verona, Italy

  • Medicina Interna Universitaria (Guido Baccelli) Azienda Ospedaliera Policlinico Consorziale

    Bari, Italy

  • Reumatologia e Immunologia Clinica, Humanitas Research Hospital

    Rozzano, Italy

  • SC (U.C.O.) Medicina Clinica Azienda Sanitaria Universitaria Giuliano Isontina (ASU GI)

    Trieste, Italy

  • SCDU Immunologia e Allergologia AO Ordine Mauriziano, University of Turin

    Turin, 10128, Italy

  • SOD Clinica Medica, Dip. Medicina Interna- Ospedali Riuniti Marche-AOU delle Marche

    Ancona, Italy

  • SYNERGO - Institute of Clinical Immunotherapy and Advanced Biological Treatmets-Casa di Cura Pierangeli S.r.l.

    Pescara, Italy

  • Struttura complessa Allergologia Immunologia Clinica e Reumatologia.Azienda Socio Sanitaria Territoriale di Mantova

    Mantua, Italy

  • Struttura organizzativa Dipartimentale Complessa Immunologia e Terapie Cellulari, A.O.U. Careggi

    Florence, Italy

  • U.O. di Medicina, Ospedale Civile "Santa Maria della Sapienza"

    Battipaglia, Italy

  • UO Immunoallergologia clinica, Azienda Ospedaliero Universitaria Pisana

    Pisa, Italy

  • UOC Clinica Immunologica e Reumatologica, A.O.U. San Giovanni di Dio e Ruggi d'Aragona

    Salerno, Italy

  • UOC di Medicina Interna e Nutrizione Clinica -Policlinico Umberto I

    Roma, Italy

  • Unità di Immunologia, Reumatologia, Allergologia e Malattie Rare all'IRCCS Ospedale San Raffaele di Milano

    Milan, 20132, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.